Furthermore, this development provides contract manufacturers with good prospects for developing and manufacturing biological products. The time aspect should not be underestimated – 8-12 years from the beginning to product launch is a general rule. What are the possibilities to speed up and optimise the process of development to manufacturing? Do modern methods in analysis and microbiology provide the chance to save time and costs? Further, are QbD and Process Validation benefits or constraints?
This conference will help to find answers.
To find out more please visit www.vaccines-conference.org.